|
|
||||||||
The Journal of Immunology, Vol 143, Issue 7 2311-2316, Copyright © 1989 by American Association of Immunologists
ARTICLES |
ME Rothenberg, J Petersen, RL Stevens, DS Silberstein, DT McKenzie, KF Austen and WF Owen Jr
Department of Medicine, Harvard Medical School, Boston, MA 02115.
Human peripheral blood-derived eosinophils were assessed for their viability, density, and functional properties after 7 days of culture with purified mouse IL-5 and mouse 3T3 fibroblasts. Whereas none of the eosinophils remained viable after 7 days of culture in the absence of IL-5, 38 +/- 12% and 61 +/- 14% (n = 6, mean +/- SD) of the eosinophils survived in the presence of 1 pM IL-5 alone or 1 pM IL-5 in the presence of 3T3 fibroblasts, respectively (p less than 0.05). Direct contact between the fibroblasts and the eosinophils was not needed for this enhanced IL-5-dependent viability. After 7 days, 66 +/- 7% (n = 6) of the cocultured eosinophils were viable when the two cell types were separated by a 0.4-microns filter. As assessed by density-gradient centrifugation after 7 days of IL-5 exposure, all of the original normodense eosinophils became hypodense. The time course of this conversion was accelerated by the presence of 3T3 fibroblasts. Enhanced helminthic cytotoxicity was maintained by the 7-day cultured eosinophils only if they had been cocultured with fibroblasts. Eosinophils killed 10 +/- 11% (n = 5), 48 +/- 17%, and 31 +/- 15% of the larvae when they were cultured for 7 days in IL-5 alone, in IL-5 in direct contact with 3T3 fibroblasts, or in IL-5 with filter separation of the fibroblasts and the eosinophils, respectively. The ability of IL- 5 to induce progenitor cells to differentiate selectively into eosinophils, and of 3T3 fibroblasts to facilitate the IL-5-mediated conversion of normodense eosinophils to hypodense eosinophils with increased viability and antibody-dependent cytotoxicity suggests a role for both hematopoietic and tissue factors in determining the presence and pathobiologic function of activated hypodense eosinophils in patients with hypereosinophilic conditions.
This article has been cited by other articles:
![]() |
R. Geoffrey, S. Jia, A. E. Kwitek, J. Woodliff, S. Ghosh, A. Lernmark, X. Wang, and M. J. Hessner Evidence of a Functional Role for Mast Cells in the Development of Type 1 Diabetes Mellitus in the BioBreeding Rat J. Immunol., November 15, 2006; 177(10): 7275 - 7286. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xue, S. L. Gyles, F. R. Wettey, L. Gazi, E. Townsend, M. G. Hunter, and R. Pettipher Prostaglandin D2 Causes Preferential Induction of Proinflammatory Th2 Cytokine Production through an Action on Chemoattractant Receptor-Like Molecule Expressed on Th2 Cells J. Immunol., November 15, 2005; 175(10): 6531 - 6536. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Kimzey, P. Liu, and J. M. Green Requirement for CD28 in the Effector Phase of Allergic Airway Inflammation J. Immunol., July 1, 2004; 173(1): 632 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Kay and A. Menzies-Gow Eosinophils and Interleukin-5: The Debate Continues Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1586 - 1587. [Full Text] [PDF] |
||||
![]() |
P. T. Flood-Page, A. N. Menzies-Gow, A. B. Kay, and D. S. Robinson Eosinophil's Role Remains Uncertain as Anti-Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 199 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Robertson, J. G. Zangrilli, A. Steplewski, A. Hastie, R. G. Lindemeyer, M. A. Planeta, M. K. Smith, N. Innocent, A. Musani, R. Pascual, et al. Differential Expression of TRAIL and TRAIL Receptors in Allergic Asthmatics Following Segmental Antigen Challenge: Evidence for a Role of TRAIL in Eosinophil Survival J. Immunol., November 15, 2002; 169(10): 5986 - 5996. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thivierge, M. Doty, J. Johnson, J. Stankova, and M. Rola-Pleszczynski IL-5 Up-Regulates Cysteinyl Leukotriene 1 Receptor Expression in HL-60 Cells Differentiated into Eosinophils J. Immunol., November 1, 2000; 165(9): 5221 - 5226. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Gounni, B. Gregory, E. Nutku, F. Aris, K. Latifa, E. Minshall, J. North, J. Tavernier, R. Levit, N. Nicolaides, et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils Blood, September 15, 2000; 96(6): 2163 - 2171. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Blease, B. Mehrad, T. J. Standiford, N. W. Lukacs, J. Gosling, L. Boring, I. F. Charo, S. L. Kunkel, and C. M. Hogaboam Enhanced Pulmonary Allergic Responses to Aspergillus in CCR2-/- Mice J. Immunol., September 1, 2000; 165(5): 2603 - 2611. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Varga, P. Wachholz, K. T. Nouri-Aria, A. Verhoef, C. J. Corrigan, S. J. Till, and S. R. Durham T Cells from Human Allergen-Induced Late Asthmatic Responses Express IL-12 Receptor {beta}2 Subunit mRNA and Respond to IL-12 In Vitro J. Immunol., September 1, 2000; 165(5): 2877 - 2885. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Evans, M. A. Lindsay, B. L. J. Webb, H. Kankaanranta, M. A. Giembycz, B. J. O'Connor, and P. J. Barnes Expression and activation of protein kinase C-zeta in eosinophils after allergen challenge Am J Physiol Lung Cell Mol Physiol, August 1, 1999; 277(2): L233 - L239. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Adachi, S. Stafford, S. Sur, and R. Alam A Novel Lyn-Binding Peptide Inhibitor Blocks Eosinophil Differentiation, Survival, and Airway Eosinophilic Inflammation1, 2 J. Immunol., July 15, 1999; 163(2): 939 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Cowburn, S. T. Holgate, and A. P. Sampson IL-5 Increases Expression of 5-Lipoxygenase-Activating Protein and Translocates 5-Lipoxygenase to the Nucleus in Human Blood Eosinophils J. Immunol., July 1, 1999; 163(1): 456 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Hallsworth, C. P. C. Soh, C. H. C. Twort, T. H. Lee, and S. J. Hirst Cultured human airway smooth muscle cells stimulated by interleukin-1beta enhance eosinophil survival. Am. J. Respir. Cell Mol. Biol., December 1, 1998; 19(6): 910 - 919. [Abstract] [Full Text] |
||||
![]() |
M. Larche, S. J. Till, B. M. Haselden, J. North, J. Barkans, C. J. Corrigan, A. B. Kay, and D. S. Robinson Costimulation Through CD86 Is Involved in Airway Antigen-Presenting Cell and T Cell Responses to Allergen in Atopic Asthmatics J. Immunol., December 1, 1998; 161(11): 6375 - 6382. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Adachi and R. Alam The mechanism of IL-5 signal transduction Am J Physiol Cell Physiol, September 1, 1998; 275(3): C623 - C633. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. TILL, S. R. DURHAM, K. RAJAKULASINGAM, M. HUMBERT, D. HUSTON, R. DICKASON, A. B. KAY, and C. J. CORRIGAN Allergen-induced Proliferation and Interleukin-5 Production by Bronchoalveolar Lavage and Blood T Cells after Segmental Allergen Challenge Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 404 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-U. Simon, S. Yousefi, B. Dibbert, H. Hebestreit, M. Weber, D. R. Branch, K. Blaser, F. Levi-Schaffer, and G. P. Anderson Role for Tyrosine Phosphorylation and Lyn Tyrosine Kinase in Fas Receptor-Mediated Apoptosis in Eosinophils Blood, July 15, 1998; 92(2): 547 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Grewe, W. Czech, A. Morita, T. Werfel, M. Klammer, A. Kapp, T. Ruzicka, E. Schopf, and J. Krutmann Human Eosinophils Produce Biologically Active IL-12: Implications for Control of T Cell Responses J. Immunol., July 1, 1998; 161(1): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Okada, J. B. Hagan, M. Kato, J. L. Bankers-Fulbright, L. W. Hunt, G. J. Gleich, and H. Kita Lidocaine and its Analogues Inhibit IL-5-Mediated Survival and Activation of Human Eosinophils J. Immunol., April 15, 1998; 160(8): 4010 - 4017. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hebestreit, B. Dibbert, I. Balatti, D. Braun, A. Schapowal, K. Blaser, and H.-U. Simon Disruption of Fas Receptor Signaling by Nitric Oxide in Eosinophils J. Exp. Med., February 2, 1998; 187(3): 415 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yuan, K. F. Austen, D. S. Friend, M. Heidtman, and J. A. Boyce Human Peripheral Blood Eosinophils Express a Functional c-kit Receptor for Stem Cell Factor that Stimulates Very Late Antigen 4 (VLA-4)-mediated Cell Adhesion to Fibronectin and Vascular Cell Adhesion Molecule 1 (VCAM-1) J. Exp. Med., July 21, 1997; 186(2): 313 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ochi, N. H. De Jesus, F. H. Hsieh, K. F. Austen, and J. A. Boyce IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production PNAS, September 12, 2000; 97(19): 10509 - 10513. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |